Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide.
about
Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanomaDendritic cell vaccines: A review of recent developments and their potential pediatric application.The development of dendritic cell vaccine-based immunotherapies for glioblastoma.Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.Revisiting GM-CSF as an adjuvant for therapeutic vaccines.
P2860
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Severe adverse immunologic rea ...... dose-intensified temozolomide.
@ast
Severe adverse immunologic rea ...... dose-intensified temozolomide.
@en
type
label
Severe adverse immunologic rea ...... dose-intensified temozolomide.
@ast
Severe adverse immunologic rea ...... dose-intensified temozolomide.
@en
prefLabel
Severe adverse immunologic rea ...... dose-intensified temozolomide.
@ast
Severe adverse immunologic rea ...... dose-intensified temozolomide.
@en
P2093
P2860
P50
P1476
Severe adverse immunologic rea ...... dose-intensified temozolomide.
@en
P2093
Duane A Mitchell
Elias J Sayour
Elizabeth Reap
Gabriel DeLeon
Gary Archer
John H Sampson
Pamela Norberg
Robert Schmittling
P2860
P304
P356
10.1158/2326-6066.CIR-14-0100
P577
2014-11-11T00:00:00Z